ANN ARBOR - Eran Bashan, CEO of Hygieia, explains how his d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app
LIVONIA - With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program. “Ninety percent
ANN ARBOR - Infectious disease expert Fred Brown tells you what to do should you want to fly on a commercial aircraft flight to avoid catching COVID-19 and giving it to anyone else. President | Chief Operating Officer Fred Brown Management Consulting C-suite strategy and operations consulting to healthcare providers, insurers and suppliers. • COO
ANN ARBOR—The Biotechnology Innovation Organization (BIO), the life science industry’s trade and lobbying group, has released its ninth biennial report, “The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities,” which highlights Michigan as a top state for the biosciences. The report studies the state of the U.S. bioscience industry and its associated innovation
LANSING – The Michigan Health Endowment Fund and several funding partners are coming together to provide $2.95 million to help 61 Michigan providers and safety net organizations ramp up telehealth efforts, which can help patients access critical care without putting themselves, their families, or their doctors at risk. While many providers have already planned for
ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses a new mechanism of action to reduce low-density lipoprotein (LDL-C), the so-called bad cholesterol in the bloodstream, the cholesterol that can cause arterial blockages that
GRAND RAPIDS—In response to the COVID-19 outbreak, Priority Health announced that it will be expanding its existing $0 copay telehealth, also known as virtual care, to include all lines of business through April 30. This means that essentially all of the company’s nearly one million members across commercial, individual, Medicaid and Medicare plans, will now
TROY—Automation Alley is requesting help from its members identifying suppliers and providers of personal protective equipment and medical supplies in response to the coronavirus pandemic. The survey is sponsored by the National Council of Textile Organization, the Industrial Fabrics Association International, and the Association of the Nonwoven Fabrics Industry. The survey is intended to identify
ANN ARBOR—Cholesterol-lowering drug developer Esperino Therapeutics Inc. has appointed Alan Fuhrman as a Class III director, with a term expiring at the 2022 meeting of stockholders. “On behalf of the Lipid Management team and our directors, I am very pleased to welcome Alan to the Esperion board. His extensive financial leadership experience will be extremely
TRAVERSE CITY – Two Traverse City companies are working together to offer drive-through COVID-19 testing centers that would include the tent to house staff and the software that would facilitate testing and samples that would be sent to laboratories to determine if the person tested has coronavirus. Russell Schindler, CEO of SampleServe, has spent more
